Spinal Stenosis Surgical Treatment Options

When a patient’s pain cannot be controlled with non-surgical treatment options alone, a surgical procedure may be recommended to remove the pressure from the nerves and stabilize the spine. 

coflex® Interlaminar Technology

One of these procedures involves the coflex® Interlaminar Technology. After the surgeon removes the bone or ligament causing compression of the nerves in the spinal canal, the coflex® device is placed in the spine to prevent future pressure on the nerves, thus allowing you to have lasting pain relief. This procedure is an alternative to more invasive procedures such as fusion surgery, which permanently joins vertebrae together. The coflex® procedure minimizes trauma to tissue with little additional surgical time and blood loss. Most patients go home within one to two days after surgery, with few activity restrictions. 

When coflex® was compared to fusion in our FDA clinical study*, patients receiving the coflex® device experienced:

  • Shorter operating time and hospital stay
  • Quicker recovery
  • Faster and sustained pain relief
  • Greater movement in the treatment area
  • More natural movement in other areas

Other Surgical Options

  • Pedicle Screw System

    • Another way to treat spinal stenosis is to fuse the spine. Pedicle screw spinal fusion involves removing the pressure from the spinal nerves, followed by insertion of metal screws and rods into your back to stabilize the spine until the bone grows together.

  • Interspinous Process Distraction Devices 

    • These devices are placed between a part of the vertebra in the back, but do not allow the surgeon to directly remove the pressure off the nerves.

Disclaimer: Although the coflex® device provides tremendous benefits to many patients, it is not for everyone. This content is for educational purposes only and does not replace having a conversation with your doctor. 
*The data is based on a randomized FDA clinical study comparing the coflex® Interlaminar Technology to the standard of care, fusion surgery. The study consisted of 322 randomized patients (215 coflex® 107 fusion) at 21 clinical centers.